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Abstract
Background: Hypertension is a clinical condition that manifests target-organ damage (TOD) with symptoms. This
study investigates the association between Zangfu patterns and symptomatic manifestations of TOD.
Methods: Datasets with manifestations of Zangfu patterns (Liver-fire blazing upwards; Kidney-yin deficiency and
Liver-yang rising; obstruction of phlegm and dampness of Heart/Liver/Gallbladder; qi and blood deficiency leading
to Liver-yang rising; Kidney-yin/yang deficiency) and TODs (cerebrovascular, heart and kidney) were compiled from
literature. The Pattern Differentiation Algorithm was used to test and to determine diagnostic accuracy with these
datasets. A questionnaire was developed from datasets and applied to 43 subjects newly diagnosed with
hypertension. Pattern differentiation was performed and the results were statistically analyzed for association
between descriptions of patterns and TOD.
Results: The observed diagnostic accuracy, sensitivity and specificity were 98.0%, 96.2% and 99.8% respectively.
Similarity between patterns and TOD datasets was mostly negligible. Twelve manifestations demonstrated high
prevalence, namely red tongue (81.4%), headache (72.1%), irritability (67.4%), palpitation (60.5%), blurred vision,
insomnia and mental fatigue (58.1%), frequent nocturnal urination, numbness in feet and hands, shortness of
breath (55.8%), and heavy limbs sensation, wiry pulse (51.2%). No significant association was found between blood
pressure variables (systolic, diastolic, mean, pulse pressure) and manifestations.
Conclusion: Zangfu patterns are associated with clinical manifestations of TOD. Manifestations associated patterns
indicate morbid conditions to be secondary to hypertension rather than simple blood pressure.
Background
Morbidity research on diseases and patterns
Ancient Chinese medicine literature [1-4] is rich in
records of patterns, the Chinese medicine nosological
counterpart of disease. Morbidity studies based on Chi-
nese medicine clinical records enhanced practitioner
development and training that lead to improved patient
care, research programs, public policy and evidence-
based commissioning [5,6].
In contemporary Chinese medicine literature [7-12],
diseases were assigned to patterns based on matched
‘signs and symptoms’ (ie manifestations) to integrate
both medical practices. For instance, studies were con-
ducted in the last two decades for cervical spine cancer
(254 cases) [13], frequently recurring cystitis (61 women)
[14], hepatocyrrhosis (223 cases [15] and 147 cases [16]),
and gastric cancer (767 cases) [17]. Morbidity research of
disease-related patterns was advised to focus on public
health disorders such as cardiovascular diseases, the prin-
cipal cause of death in modern society [18].
Chinese medicine patterns in cardiovascular diseases
Morbidity studies were conducted for variant angina
pectoris (175 cases) [19], stable angina pectoris (251
cases) [20] and acute ischemic stroke (1246 cases) [21].
Despite the worldwide high prevalence of hypertension
as the major risk factor for cardiovascular diseases [18],
only five Chinese medicine morbidity studies on it were
found in literature. As Chinese medicine diagnosis could
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improve efficacy and/or diminish adverse effects of anti-
hypertensive agents [22], the morbidity of patterns in
hypertension must be studied.
Kalish et al. [23] reported the Stop Hypertension with
the Acupuncture Research Program trial (a pilot rando-
mized clinical trial on the efficacy of acupuncture in
treating essential hypertension), which was expected to
find Zangfu patterns in hypertension. A randomized
controlled trial [24] on acupuncture treatment for
hypertension enrolled 192 patients and the frequency of
Zangfu patterns was recorded. However, no data related
to observed manifestations were given and no associa-
tion was investigated between clinical findings (eg blood
pressure) and patterns. Flachskampf et al. [25] rando-
mized the allocation of 160 outpatients with uncompli-
cated hypertension in a single-blind fashion to a 6-week
course of acupuncture intervention; however, they did
not report descriptive statistics on patterns or manifesta-
tions or association analysis. Chu et al. [26] reported 59
cases of hypertension classified according to whether or
not abundant phlegm-dampness was presented for ana-
lysis of proteome. Again, no analysis was conducted to
explore the frequency distribution of patterns or its
manifestations. Gu et al. [27] investigated the frequency
distributions of patterns in 477 untreated subjects with
hypertension and did not find statistical significance in
the frequency distributions of patterns within blood
pressure levels, age or body mass index (BMI). This het-
erogeneity of analysis regarding patterns in subjects with
hypertension led to the reports of opposite results of
acupuncture treatment for lowering mean 24-hour
ambulatory blood pressures.
Diagnosis and prognosis of hypertension in Chinese
medicine and conventional medicine
As hypertension may be symptomless until late in its
course, previous guidelines for management of hyper-
tension advised that its diagnosis should be based on
multiple systolic (SBP) and diastolic blood pressure
(DBP) measurements (≥ 140 and 90 mmHg respectively)
taken on separate occasions over time [28]. A recent
study indicated that both family and clinical histories
would be required for prognosis in patients with high
blood pressure [29]. Current knowledge of hypertension
emphasizes the role of structural changes in microcircu-
lation (such as arteriolar rarefaction [30,31]) in hyper-
tension pathogenesis and hypertension-related organ
damage [32]. Concomitantly, hypertrophied or remo-
deled medium-sized vessels [33] and stiffened large
arteries [34] are the basis of hypertension-induced organ
damage in the brain (and eyes), heart or kidneys [32]. In
general, changes in blood flow and pressure are not
significant until approximately 50% of the vessel dia-
meter is obstructed [35]. Thus, hypertensive patients’
manifestations may indicate the progression or worsen-
ing of those target-organ damages (TOD).
On the other hand, Chinese medicine practitioners
rely on information collected from the Four Methods
(FM, sizhen) of examination, namely inspection (wang),
auscultation and olfaction (wen), inquiry (wen) and pal-
pation (qie), and do not use blood pressure measures for
pattern differentiation on patients with hypertension.
Contemporary literature on Chinese medicine diagnosis
[7-12] and clinical research [23,24,27] assign up to five
Zangfu patterns to hypertension based only on manifes-
tations. This discrepancy between Chinese medicine and
conventional medicine raises the question whether pat-
terns are indeed related to high blood pressure levels or
to TOD caused by chronic hypertension. However, no
previous study on morbidity of hypertension-related pat-
terns [23-27] has explored the relations between pat-
terns and TOD.
This study investigates the association between Zangfu
patterns and clinical manifestations of TOD and tests a
hypothesis that patterns are associated with TOD as
manifestations associated patterns indicate morbid con-




The design of the present study is described in Figure 1.
Literature review of patterns and TOD was performed
to generate datasets for Chinese medicine and conven-
tional medicine. The diagnostic accuracy of Pattern Dif-
ferentiation Algorithm (PDA) for Chinese medicine
diagnosis was tested for the constructed hypertension
dataset. A questionnaire for clinical assessment of
patients was generated from hypertension dataset and
applied to subjects with hypertension (according to elec-
tronic health records). Statistical analysis was conducted
to test the association between descriptions of patterns
and TOD. The present study followed the guidelines for
the Strengthening the Reporting of Observational Stu-
dies in Epidemiology (STROBE) [36].
Development of pattern dataset and questionnaire
Patterns were collected from contemporary literature
[7-12,23,24,27], according to which, five Zangfu patterns
describing subjects with hypertension are as follows.
Liver-fire blazing upwards (gan huo shang yan); Kidney-
yin deficiency and Liver-yang rising (shen yin xu gan
yang shang yan); Obstruction of phlegm and dampness
of Heart/Liver/Gallbladder (xin gan dan shi tan bi); Qi
and blood deficiency leading to Liver-yang rising (qi xue
xu gan yang shang yan); and Kidney-yin/yang deficiency
(shen yin yang xu). These patterns had their respective
manifestations annotated according to the FM to
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compose the widest description of each pattern, namely
Zangfu hypertension dataset (ZFHD, Table 1). Possible
descriptions to distinguish manifestations included its
onset, duration, location, progression and severity (Addi-
tional file 1).
The questionnaire was automatically generated from
ZFHD by an algorithm as follows. Since patterns may
share manifestations (co-occurrence of terms), all patterns
in ZFHD were merged and their respective manifestations
cited only once. Then, the dataset was submitted to a two-
stage processing scheme for intra-pattern and inter-pat-
tern quality control [37,38]. The resulting Zangfu hyper-
tension questionnaire (ZFHQ) was composed of 38
manifestations distributed among inspection (n = 7;
18.4%), auscultation-olfaction (n = 2; 5.3%), inquiry (n =
23; 60.5%) and palpation (n = 6; 15.8%).
Development of TOD dataset: Correspondence between
patterns and TOD
To analyze the association between descriptions of pat-
terns and TOD, we redistributed the manifestations in
ZFHD per target-organ within each examination
method to compose the TOD dataset (TODD, Table 1).
Most of the signs and symptoms describing patterns
were easily recognized as corresponding to cerebrovas-
cular, heart or kidney lesions [29,39-47]; however, some
manifestations particularly related to tongue inspection
and pulse palpation due to predominant qualitative
descriptions were not explored [48]. In this study, the
following manifestations were assigned based on the
argument that a strong correlation (r = 0.74; P = 0.001)
was found between a thick yellow or gray tongue coat-
ing and halitosis resulting from infection with specific
Figure 1 Study design. Literature review of Zangfu patterns and TOD was performed to generate both datasets and questionnaire. A
computer-based method for CM diagnosis was validated for the constructed hypertension dataset. The questionnaire was applied to patients
and the results were analyzed test the association between Zangfu patterns and TOD.
Luiz et al. Chinese Medicine 2011, 6:23
http://www.cmjournal.org/content/6/1/23
Page 3 of 12
bacterial species such as Solobacterium moorei which
produces high levels of volatile sulfur compounds. Evi-
dence suggested that even low concentrations of those
compounds might be toxic and played a role in the link
between oral infection and either heart [49] or cerebro-
vascular disease [50]. Conversely, the peeled (without
coat) tongue was found to appear in subjects with
healthy periodontal tissues [51]. The pallor observed in
anemia, a common feature of chronic kidney failure
[42], was better identified at the tongue compared to
conjunctivae, palms or nail beds and tongue pallor
might rule out and modestly rule in severe anemia [52].
All remaining manifestations were not assigned to TOD
and consequently not used in the current analysis. The
resulting TODD was composed by 27 manifestations
distributed among inspection (n = 4; 14.8%), ausculta-
tion-olfaction (n = 2; 7.4%), inquiry (n = 20; 74.1%) and
palpation (n = 1; 3.7%).
Table 1 Chinese medicine patterns of systemic arterial hypertension
Examination method Manifestations Patterns Target-organs
Inspection Flushed face A[8,24] *
Grease and thick coating C[8,24] CVD[51], HD[51]
Pale tongue E[8,24] KD[43,53]
Peeled tongue B[24] *
Red eyes A[8] CVD[40], KD[41]
Red tongue A[10,24], B[8,24] *
Yellow coating A[8,24] CVD[51], HD[51]
Auscultation-Olfaction Aphasia D[8] CVD[47,43]
Shortness of breath E[8,24] HD[47,43]
Inquiry Blurred vision B[8,24] CVD[47], KD[44]
Congested feeling in the chest C[8,24] HD[47]
Constipation A[8,24] KD[45]
Convulsions D[8] CVD[44,43]
Dizziness B[8,24], C[8], E[24] CVD[47]
Excessive dreaming B[8] *
Fainting D[8] CVD[44]
Frequent nocturnal urination E[8,24] KD[44]
Headache A[8,10,24], B[24], D[8] CVD[47,44], KD[44]
Heavy limbs sensation C[8] CVD[52]
Impotence E[8,24] *
Insomnia B[8,24] CVD[48], HD[48], KD[48]
Irritability A[8,10,24] *
Mental fatigue E[8,24] KD[45]
Nausea C[8,24] CVD[44,43], KD[46]
Numbness in feet and hands E[8] CVD[47,43]
Numbness in the limbs B[8,24], C[8] CVD[47,43]
Palpitation C[8] HD[47,43]
Severe dizziness D[8,24] CVD[47]
Stroke D[8] CVD[47,43]
Tinnitus A[10], B[8,24], E[8,24] CVD[42]
Vomiting C[8] CVD[52], KD[46]
Weak legs E[8] CVD[47,43], KD[44]
Palpation Deep pulse E[8,24] *
Fast pulse A[8,24], B[8,24] HD[47]
Slippery pulse C[8,24] *
Strong pulse A[8] *
Thin pulse B[8],24, E[8,24] *
Wiry pulse A[8,10,24], B[8,24], C[8], D[24] *
Chinese medicine classification and description of patterns and respective target-organs related to hypertension.
Legends: A: Liver-fire blazing upwards; B: Kidney-yin deficiency and Liver-yang rising; C: Obstruction of phlegm and dampness of Heart/Liver/Gallbladder; D: Qi
and blood deficiency leading to Liver-yang rising; E: Kidney-yin/yang deficiency; CVD: cerebrovascular and eye disease; HD: heart disease; KD: kidney disease.
Manifestations not considered as related to specific target-organs were marked as * and were not used for inference about target-organ damage.
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Subject recruitment
The study was conducted with a sample of patients from
National Institute of Cardiology (Rio de Janeiro, Brazil)
after the Medical Ethics Committee had approved the
protocol (trial register number 0239/02.06.09). Written
informed consent was obtained from all subjects in the
study. Subjects newly diagnosed with hypertension were
prospectively recruited from January 2009 to July 2009
(once a week) and admitted in this study after physical
examination. The diagnostic criteria of hypertension
were systolic and diastolic arterial blood pressure ≥140 or
90 mmHg respectively, measured in two or more conse-
cutive visits at the outpatient clinic over a period of at
least seven days [29]. Patients did not report a prior use
of any antihypertensive. Metabolic diseases (such as dia-
betes mellitus) and secondary hypertension were clini-
cally investigated and ruled out in all subjects. Sample
sizes were estimated from formulae [53] designed for stu-
dies with correlation coefficient as the outcome. A mini-
mum sample size of 36 cases is required to test for the
alternative hypothesis that the correlation coefficient is
higher than 0.41 (at least weak association) with a = 5%
(significance level) and b = 80% (power of test).
Clinical variables and data measurement
Forty-three subjects (among which 26 were female) with
primary hypertension were enrolled in this study. All
procedures were performed between 08:00 and 12:00 in
a quiet room with controlled temperature (19-21°C)
immediately before the questionnaire interview. Ambu-
latory blood pressures were measured at the brachial
artery (right arm) with a mercury column sphygmoman-
ometer by the same examiner. The first and the fifth
Korotkoff’s phases were used to define SBP and DBP
respectively. Mean blood pressure (MBP = 2/3 × DBP
+1/3 × SBP) and pulse pressure (PP = SBP-DBP) were
also calculated. Additional clinical parameters were also
assessed, namely age, sex, body mass index (BMI) and
heart rate (HR). Demographic data are in Table 2.
Interview with ZFHQ was performed with all subjects
after clinical examination by the same Chinese medicine
practitioner in the presence of another Chinese medicine
doctor, each with ten years of clinical experience. The
interviewer applied the ZFHQ to patients by asking them
about the presence or absence of manifestations, marking
them accordingly in each patient’s printed questionnaire.
Reports were digitized and converted to text data (string
values, quoted terms and comma separated values) for
analysis. Additionally, a photograph of the tongue from
each patient was kept on record (Additional file 2).
Computer-based Chinese medicine pattern differentiation
Patterns in both simulated and studied sample were iden-
tified with PDA [37,38,54]. PDA provides information of
diagnostic accuracy for testing with constructed datasets.
PDA performs pattern differentiation with two quantita-
tive criteria as follows.
(1) Explained information (F%): calculated as the ratio
between the count of manifestations found in each diag-
nostic hypothesis of the dataset and the total manifesta-
tions collected at the exam. This criterion indicates the
‘strength’ of the hypothesis as the actual diagnosis con-
sidering its predominance in the clinical history [54].
(2) Available information (N%): calculated as the ratio
between the count of manifestations found in each diag-
nostic hypothesis of the dataset and the total manifesta-
tions that describe the respective diagnostic hypothesis.
A cutoff point may be subtracted from the N% value
depending on the effect of the concave-shaped curve on
PDA’s accuracy [38]. This criterion indicates the
‘strength’ of the hypothesis as the actual diagnosis con-
sidering its predominance regarding the observed
hypothesis.
PDA output indicated whether or not the pattern dif-
ferentiation was successful. Automatic pattern differen-
tiation was successful if a pattern presented the highest
amount of explained manifestations (F%) with the con-
comitant lowest amount of manifestations (N%) among
two or more diagnostic hypotheses. In other words, the
identified pattern maximally explained the clinical his-
tory with minimum available information. In addition to
Table 2 Characteristics of the studied sample
Characteristics Values
Sample (Female; Male) 43 (26; 17)
Clinical data, mean ± SD
Age, years 54.1 ± 16.2
Systolic pressure, mmHg 162.7 ±
24.8
Diastolic pressure, mmHg 98.6 ± 16.6
Mean pressure, mmHg 120.0 ±
17.5
Pulse pressure, mmHg 64.0 ± 19.3
Heart rate, b/min 70.9 ± 12.4
Body mass index, kg/m2 27.1 ± 6.3
Zangfu patterns, N (%)
Liver-fire blazing upwards 5 (11.6)
Kidney-yin deficiency and Liver-yang rising 33 (76.7)
Obstruction of phlegm and dampness of Heart/Liver/
Gallbladder
0 (0)
Qi and blood deficiency leading to Liver-yang rising 0 (0)
Kidney-yin/yang deficiency 5 (11.6)
Manifestations, median [minimum; maximum]
Presented (clinical history) 14.0 [4.0;
23.0]
Available (used in pattern differentiation) 7.0 [3.0;
10.0]
Demographic and clinical variables of subjects with hypertension
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the dichotomous output (success or failure), the output
comprised a nominal variable (name of identified pat-
tern) and two continuous, percent variables (F% and N%
criteria) indicating the strength of selection of pattern as
a diagnostic hypothesis concerning presented and
explained manifestations respectively.
Computer-based TOD inference
The present study inferred TOD occurrence with the
same method and criteria used to differentiate patterns.
In this case, the output for nominal (target-organ) and
percent variables (F% and N%) referred to descriptions of
TOD. Likewise, F% and N% indicated the strength of
inference of the target-organ as damage concerning pre-
sented and explained manifestations respectively.
Statistical Analysis
Diagnostic accuracy of the questionnaire
The accuracy of ZFHQ was tested with the manifesta-
tion profile simulation algorithm (MPSA) described pre-
viously [37,38,54] for the possibility to perform accurate
pattern differentiation of hypertension-related patterns
using PDA. Briefly, MPSA simulated true positive cases
(TP) and true negative controls (TN) manifestation pro-
files from ZFHD with variable amount of manifestations
N%. The diagnosis identified by PDA was compared
with the simulated condition. This process yielded a 2 ×
2 confusion matrix from which binomial estimators
related to diagnostic accuracy are obtained with their
respective 95% confidence intervals (95%CI). The vari-
able amount of information N% used by MPSA was then
tested for optimum accuracy results by receiver operat-
ing curve analysis. A cutoff value for N% (N%-cutoff) was
applied if a significant increase in accuracy was
observed.
Dataset analysis
Similarity analysis between ZFHD and TODD was per-
formed with the Jaccard coefficient SJ [55] to test
whether the descriptions of patterns in ZFHD were
similar to descriptions of damage to target-organs in
TODD. SJ was in range (0;1), indicating no similarity
(perfect dissimilarity) and perfect similarity respectively
[56]. However, it would not be correct to infer strong
similarity directly from high values of Jaccard’s coeffi-
cient nor to infer weak similarity from low values
because these values could be random. In turn, the ran-
dom values expected to occur will depend on the num-
ber of attributes present in the sets formed by each pair
of patterns and target-organs. Therefore, it was neces-
sary to determine whether the values of Jaccard’s coeffi-
cient in each pair differed from what would be expected
at random in order to infer their significance. Thus, the
null hypothesis was that the calculated SJ between
ZFHD and TODD was expected to occur at random
and lower and upper critical values were obtained from
tables [57] for acceptance of rejection of this null
hypothesis considering the number of manifestations in
either pattern and target-organ and the lowest number
of manifestations in both pattern and target-organ
descriptions. Since SJ is a continuous variable that repre-
sent the ‘strength’ of association between both descrip-
tions, it was categorized as an association measure [58],
ie 0.00 (no similarity); 0.01 to 0.20 (negligible); 0.21 to
0.40 (weak); 0.41 to 0.70 (moderate); 0.71 to 0.99
(strong); 1.00 (perfect similarity).
Clinical study analysis
Frequencies of manifestations among patterns and in
the whole sample were tabulated. PDA was used for
pattern differentiation and estimation of prevalence of
each pattern in the real cases sample. Additionally, both
PDA’s criteria F% and N% (both continuous variables)
were also calculated for the association analysis
described as follows. Pearson product moment correla-
tion was used to calculate the association between the
manifestations (dichotomous variables) and hemody-
namic data (continuous variables). Pearson correlation
coefficient (r) was also used to calculate the association
between patterns and TOD based on PDA’s diagnostic
criteria F% and N% obtained within ZFHD and TODD
respectively. All candidate patterns as well as all possi-
ble target-organs output from PDA were considered
simultaneously for this correlation analysis, ie each
patient had their diagnostic criteria calculated by PDA
for all Zangfu patterns and target-organs. Association
was also categorized according to correlation coefficient
[58], ie 0.00 (no association); 0.01 to 0.20 (negligible);
0.21 to 0.40 (weak); 0.41 to 0.70 (moderate); 0.71 to
0.99 (strong); 1.00 (perfect association). Null hypotheses
were r = 0.00 for all association tests. Statistical signifi-
cance was considered at P < 0.05.
Computational resources
All algorithms were implemented in LabVIEW 8.0
(National Instruments, USA) and executed on a 2.26
GHz Intel® Core 2 Duo microprocessor with 2.00 GB
RAM running Windows 7 (Microsoft Corporation,
USA).
Results
Diagnostic accuracy of the questionnaire
Two hundred subjects were simulated (100 true positive
[TP] and 100 true negative [TN] per pattern) by MPSA
using the FM, summing up 1,000 cases. No missing
cases were found (all cases presented at least one mani-
festation). Diagnostic accuracy with F% yielded the fol-
lowing results: TP = 481, false positive (FP) = 1, false
negative (FN) = 19 and TN = 499 cases; accuracy of
98.0% [97.3; 99.1]; sensitivity and specificity of 96.2%
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[94.9; 98.3] and 99.8% [99.6; 100.0] respectively; negative
and positive predictive values of 96.3% [95.1; 98.4] and
99.8% [99.6; 100.0] respectively. Diagnostic accuracy of
PDA using F% and N% with the optimum cutoff value
(19.0% of manifestations) obtained for N% yielded the
following: TP = 487, FP = 6, FN = 13 and TN = 494
cases; accuracy of 98.1% [97.4; 99.2]; sensitivity and spe-
cificity of 97.4% [96.3; 99.2] and 98.8% [98.2; 100.0]
respectively; negative and positive predictive values of
97.4% [96.4; 99.2] and 98.8% [98.1; 100.0] respectively.
No significant improvement (P > 0.05) was found on
diagnostic accuracy with the cutoff values for N%. Thus,
no additional cutoff was applied to N% for pattern differ-
entiation and TOD inference in the real patient sample.
Similarity between ZFHD and TODD
Similarity estimated between ZFHD and TODD is in
Table 3. There was a significant negligible (SJ≤0.20)
similarity in description between: Liver-fire blazing
upwards pattern and both CVD (SJ = 0.15 [0.19; 0.58])
and HD (SJ = 0.12 [0.13; 0.86]); Obstruction of phlegm
and dampness of Heart/Liver/Gallbladder pattern and
KD (SJ = 0.11 [0.16; 0.70]); qi and blood deficiency lead-
ing to Liver-yang rising pattern and both HD (SJ = 0.00
[0.07; 0.86]) and KD (SJ=0.06 [0.12; 0.86]); and Kidney-
yin/yang deficiency pattern and both CVD (SJ=0.15
[0.19; 0.73]) and HD (SJ=0.06 [0.12; 0.86]). No signifi-
cant similarity was found between any other descrip-
tions of patterns and TOD.
Frequency of manifestations in hypertension
Frequencies of manifestations grouped by identified
hypertension-related pattern and whole sample are in
Table 4. No pathognomonic manifestation was found
among the whole sample of subjects with hypertension.
Twelve manifestations presented high prevalence (>
50%), ie red tongue (81.4%); headache (72.1%); irritability
(67.4%); palpitation (60.5%); blurred vision, insomnia,
mental fatigue (58.1%); frequent nocturnal urination,
numbness in feet and hands, shortness of breath
(55.8%); and heavy limbs sensation, wiry pulse (51.2%).
However, ‘red tongue’ was present in all five subjects
with Liver-fire blazing upwards pattern while ‘numbness
in feet and hands’ appeared in all five subjects with Kid-
ney-yin/yang deficiency pattern.
Association between manifestations and hemodynamic
variables
SBP was weakly associated with excessive dreaming
(-0.398, P = 0.008), shortness of breath (-0.304, P =
0.047) and flushed face (0.347, P = 0.023). DBP was also
weakly associated with flushed face (0.306, P = 0.046) as
well as to palpitation (0.355, P = 0.019) and to thin
pulse (0.329, P = 0.031). MBP was weakly associated
with excessive dreaming (-0.372, P = 0.014). PP was
weakly associated with pale tongue (0.336, P = 0.028),
and conversely with red tongue (-0.336, P = 0.028),
strong pulse (0.304, P = 0.048 and shortness of breath
(-0.342, P = 0.025). All other pairs of association were
statistically no significant. After adjustment for age, sex
and BMI, none of the above pairs exhibited statistically
different values.
Association between patterns and TOD
Results of the association of the diagnostic criteria
between patterns and TOD are in Table 5. In respect of
information F%, moderate association was observed
between Liver-fire blazing upwards and KD (0.424; P =
0.004) while weak association was found between Kid-
ney-yin deficiency and Liver-yang rising with CVD
(-0.276; P = 0.037) and HD (-0.321; P = 0.019) and qi
and blood deficiency leading to Liver-yang rising and
HD (0.322; P = 0.019). No other comparison between
pattern and TOD was significantly associated.
Regarding the amount of available information N%,
Liver-fire blazing upwards pattern was moderately
















Qi and blood deficiency








0.15* [0.19; 0.58] 0.23 [0.19; 0.69] 0.26 [0.17; 0.70] 0.30 [0.15; 0.86] 0.15* [0.19; 0.73]
HD
(n = 7)
0.12* [0.13; 0.86] 0.11 [0.11; 0.86] 0.13 [0.13; 0.86] 0.00* [0.07; 0.86] 0.06* [0.12; 0.86]
KD
(n = 11)
0.16 [0.16; 0.72] 0.14 [0.14; 0.73] 0.11* [0.16; 0.70] 0.06* [0.12; 0.86] 0.22 [0.11; 0.73]
Jaccard coefficient of similarity between manifestations of patterns and target-organs damage calculated from ZFHD and TODD datasets.
* Values significantly lower than expected at random, P < 0.05. All other values not different to those expected at random were left unmarked. Values in brackets
represent critical values of SJ with a probability level of P < 0.05 considering the total number of manifestations present in either of the two patterns being
compared and the minimum quantity of manifestations between patterns and target-organs. CVD: cerebrovascular and eye disease; HD: heart disease; KD: kidney
disease.
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associated with all TOD (CVD: 0.606, P < 0.001; HD:
0.650, P < 0.001; KD: 0.462, P = 0.002). Kidney-yin defi-
ciency and Liver-yang rising pattern was moderately
associated with both CVD and HD (0.637, P < 0.001;
0.590, P < 0.001, respectively) and weakly associated
with KD (0.311; P = 0.029). Obstruction of phlegm and
dampness of Heart/Liver/Gallbladder pattern was
strongly associated with CVD (0.718, P < 0.001) and
moderately associated with both HD and KD (0.700, P <
0.001; 0.413, P = 0.005 respectively). Qi and blood defi-
ciency leading to Liver-yang rising pattern was strongly
associated with HD (0.718, P < 0.001) and moderately
associated with KD (0.651, P < 0.001). Kidney-yin/yang
deficiency pattern was moderately associated with CVD
and HD (0.584, P < 0.001; 0.488, P = 0.001 respectively).
All other comparisons yielded no significant association.
Table 4 Descriptive statistics of manifestations
Manifestations Frequency of manifestations
Liver-fire blazing
upwards
(n = 8; 18.6%)
Kidney-yin deficiency and Liver-yang
rising
(n = 30; 69.8%)
Kidney-yin/yang
deficiency
(n = 5; 11.6%)
Whole sample
(n = 43; 100%)
red tongue 5 (100.0) 28 (84.8) 2 (40.0) 35 (81.4)
headache 2 (40.0) 26 (78.8) 3 (60.0) 31 (72.1)
irritability 2 (40.0) 27 (81.8) 0 (0) 29 (67.4)
palpitation 1 (20.0) 21 (63.6) 4 (80.0) 26 (60.5)
blurred vision 1 (20.0) 21 (63.6) 3 (60.0) 25 (58.1)
insomnia 0 (0) 23 (69.7) 2 (40.0) 25 (58.1)
mental fatigue 2 (40.0) 19 (57.6) 4 (80.0) 25 (58.1)
frequent nocturnal urination 4 (80.0) 16 (48.5) 4 (80.0) 24 (55.8)
numbness in feet and hands 0 (0) 19 (57.6) 5 (100) 24 (55.8)
shortness of breath 2 (40.0) 19 (57.6) 3 (60.0) 24 (55.8)
heavy limbs sensation 1 (20.0) 17 (51.5) 4 (80.0) 22 (51.2)
wiry pulse 4 (80.0) 17 (51.5) 1 (20.0) 22 (51.2)
tinnitus 2 (40.0) 16 (48.5) 3 (60.0) 21 (48.8)
red eyes 2 (40.0) 14 (42.4) 4 (80.0) 20 (46.5)
constipation 3 (60.0) 14 (42.4) 2 (40.0) 19 (44.2)
peeled tongue 2 (40.0) 17 (51.5) 0 (0) 19 (44.2)
numbness in the limbs 1 (20.0) 16 (48.5) 1 (20.0) 18 (41.9)
dizziness 1 (20.0) 13 (39.4) 3 (60.0) 17 (39.5)
nausea 1 (20.0) 15 (45.5) 1 (20.0) 17 (39.5)
congested feeling in the
chest
1 (20.0) 13 (39.4) 2 (40.0) 16 (37.2)
weak legs 3 (60.0) 12 (36.4) 1 (20.0) 16 (37.2)
excessive dreaming 0 (0) 10 (30.3) 1 (20.0) 11 (25.6)
flushed face 1 (20.0) 8 (24.2) 2 (40.0) 11 (25.6)
thin pulse 0 (0) 9 (27.3) 2 (40.0) 11 (25.6)
impotent 1 (20.0) 7 (21.2) 2 (40.0) 10 (23.3)
strong pulse 3 (60.0) 5 (15.2) 1 (20.0) 9 (20.9)
pale tongue 0 (0) 5 (15.2) 3 (60.0) 8 (18.6)
vomiting 0 (0) 7 (21.2) 1 (20.0) 8 (18.6)
fainting 0 (0) 5 (15.2) 2 (40.0) 7 (16.3)
slippery pulse 1 (20.0) 5 (15.2) 1 (20.0) 7 (16.3)
yellow coating 3 (60.0) 4 (12.1) 0 (0) 7 (16.3)
fast pulse 1 (20.0) 4 (12.1) 0 (0) 5 (11.6)
severe dizziness 0 (0) 4 (12.1) 1 (20.0) 5 (11.6)
aphasia 0 (0) 3 (9.1) 1 (20.0) 4 (9.3)
stroke 1 (20.0) 2 (6.1) 1 (20.0) 4 (9.3)
deep pulse 0 (0) 1 (3.0) 2 (40.0) 3 (7.0)
convulsions 0 (0) 1 (3.0) 0 (0) 1 (2.3)
Frequencies of manifestations in the studied sample according to Zangfu patterns (manifestations were arranged in decreasing order of occurrence).
Values are shown as: absolute frequency (%).
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Discussion
The main result of the present study is that Zangfu
patterns were strongly or moderately associated with
clinical manifestations of TOD in subjects with hyper-
tension. Moreover, clinical manifestations were at most
(all r < 0.40) weakly associated with hemodynamic
variables.
Relationship between Chinese medicine patterns and
TOD in hypertension
The results of this study indicated that all Zangfu pat-
terns were strongly (up to r = 0.718) or moderately
associated with two or three target-organs due to hyper-
tension by the amount of available information N%.
These results were much less (up to r = 0.424) pro-
nounced when association was tested with the explained
information F% criterion. More interestingly, those
results occurred in spite of the negligible similarity
between theoretical descriptions in both ZFHD and
TODD datasets. Altogether, these results indicate that
the amount of information that explains a single pattern
is directly proportional to the amount of information
explained by the investigated target-organs for any
quantity of manifestations in either clinical history or
pattern. In other words, although patterns share no sig-
nificant amount of manifestations with target-organs,
the quantity of manifestations explained by a pattern is
almost linearly proportional to the quantity of explained
manifestations compatible with TOD in the same
patient. The present study investigates such integrative
relationship whereas other studies on morbidity of pat-
terns in hypertension focused on descriptive statistics of
patterns [27], therapeutic interventions [23-25] and pro-
teomic analysis of dichotomous classes of patterns [26].
Chinese medicine pattern differentiation considers the
presence or absence of manifestations in the exterior of
the body, together with the individual constitutional
characteristics, to differentiate the pattern inside the
body, ie the internal organs and viscera. A pattern indi-
cates the progress of a morbid condition at a certain
phase, as well as the cause, nature, location, manifesta-
tion and prognosis of the condition. That is why differ-
ent diseases may be associated with the same pattern
and the same disease may be associated with different
patterns [7-12]. The strength of this association is
expected to vary with the similarity between descriptions
of each pattern and disease (ie co-occurrence of mani-
festations) [38] and other factors such as relations to tis-
sues, organs and systems functional interdependency,
family history and environmental etiology [59].
In Chinese medicine, the amount of manifestations is
a measure of the severity and progression of patterns
[9], ie patterns under development are described by a
small amount of manifestations (low N% values) while
severe patterns usually presents with a large amount of
manifestations (high N% values). The explained informa-
tion criterion is based on the holistic approach that ‘all
manifestations must be interpreted collectively’ [9,54]
and thus is more influenced by co-occurrence than N%,
which explains the strong correlation found between
patterns and TOD with N% but not with F%.
By contrast, in conventional medicine, subclinical find-
ings of diseases must be assessed with clinical and labor-
atorial examinations. The presence of ‘silent’,
asymptomatic TOD (eg left ventricle hypertrophy, caro-
tid atherosclerosis, diminished glomerular filtration rate,
increased serum creatinine and microalbuminuria) in
subjects with hypertension is already an indicator of dis-
ease progression. Silent TOD is estimated to occur in in
61.3% (any TOD) of subjects with hypertension while
50.3% of the hypertensive patients presented a single
silent TOD, 31.0% two TOD and 18.7% presented three
or more [60]. If left untreated, subclinical hypertension
may lead to localized microvascular lesions (athero-
sclerosis) which can progress into diffuse (arteriosclero-
sis) lesions, affecting target-organs and producing
various manifestations [32], ie silent TOD slowly pro-
gresses to symptomatic TOD. Because of the progres-
sion of structural damages, hypertension can be
undiscovered for 10-20 years [61] and the overall










Obstruction of phlegm and
dampness of Heart/Liver/
Gallbladder






CVD F% -0.153 -0.276* -0.009 0.188 -0.141
N% 0.606
† 0.637† 0.718† 0.651† 0.584†
HD F% -0.188 -0.321* -0.048 0.322* -0.263
N% 0.650
† 0.590† 0.700† 0.718† 0.488§
KD F% 0.424
§ 0.087 0.124 -0.244 -0.096
N% 0.462
§ 0.311* 0.413§ 0.248 0.234
Pearson correlation coefficient calculated between diagnostic criteria F% and N% for each Zangfu pattern and target-organ in the studied sample.
*P < 0.05; §P < 0.01; †P < 0.001. CVD: cerebrovascular and eye disease; HD: heart disease; KD: kidney disease.
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prevalence of clinically manifested TOD can be as high
as 95% for stroke (CVD), 89% for left ventricular hyper-
trophy (HD) and 95% for kidney failure (KD) [62].
Although this study does not present data regarding
silent TOD to guarantee that patients actually present
any degree of TOD - in fact, for some manifestations is
not quite necessary (eg stroke) - the collective results of
this first study strongly indicate that the five Zangfu pat-
terns commonly used for pattern differentiation in
patients with hypertension are indeed related to hyper-
tension-induced TOD. Further studies should focus on
subclinical findings in hypertension and their relation-
ship with symptomatic hypertensive patients and Chi-
nese medicine patterns.
Frequency distribution of patterns and manifestations
The frequency distribution of patterns observed in this
sample is in agreement with previously studies. Maklin
et al. [24] reported that Kidney-yin deficiency and Liver-
yang rising (shen yin xu gan yang shang yan) was the
most prevalent pattern (47-63%), followed by obstruc-
tion of phlegm and dampness of Heart/Liver/Gallblad-
der (xin gan dan shi tan bi) (19-30%), Liver-fire blazing
upwards (gan huo shang yan) (13-17%), qi and blood
deficiency leading to Liver yang rising (qi xue xu gan
yang shang yan) (2-6%) and Kidney-yin/yang deficiency
(shen yin yang xu) (0-3%). Gu et al. [27] found stagna-
tion of phlegm-dampness (zhi shi tan) to be the most
prevalent pattern (27%), followed by hyperactivity of the
Liver-yang (gan yang shang yan) (24%), deficiency of
Heart/Kidney-Qi (xin shen qi xu) (10%), blood stasis
obstructing the collaterals (luo xue yu bi) (9%), defi-
ciency of yin and yang (yin yang xu) (8%) while other
syndromes accounted for 21% of the sample. Why pat-
terns related to Liver-yang and phlegm-dampness are
the most prevalent is still unknown. Emotional states,
family history and food habits play important roles in
the etiology of these patterns and are considered as
major risk factors to hypertension by both Chinese med-
icine [9,11] and conventional medicine [29].
Association between manifestations, patterns, and
hemodynamic data
High blood pressure levels should be symptomless; how-
ever, patients and physicians usually attribute symptoms
to increased levels of blood pressure. The weak signifi-
cant association between manifestations and blood pres-
sure variables observed in this study were not held
under adjustment for age, sex and BMI. These results
agree with the physiologic knowledge on blood pressure
control and with other epidemiologic reports according
to which symptoms were not significantly correlated to
hypertension [63,64], patterns [27] or proved uncorre-
lated when adjusted to confounding variables [65] or
awareness of hypertension [66]. In the present study,
association tests were performed with the entire sample
of hypertensive subjects. It is possible that predomi-
nance of Kidney-yin deficiency and Liver-yang rising
pattern lead to biased results. Further studies may
search for such correlations with the sample divided
into equally distributed subgroups regarding all identi-
fied patterns and subsample sizes.
Using manifestations to bridge the gap between Chinese
medicine and conventional medicine
The present study regards the patient as the common ele-
ment to both medical practices. Chinese medicine practi-
tioners and physicians interpret clinical manifestations
according to their medical training and may not rely on
information provided by laboratories and medical imaging.
Conventional medicine considers the manifestations of
hypertension-induced TOD as consequences of progres-
sive, structural lesions to arteries that progressively com-
promise blood flow to and cell metabolism of vital organs.
Chinese medicine interprets the same manifestations as
due to chronic, functional imbalances of organs and vis-
cera that result in Zangfu deficiency states and obstruction
or rebellion of qi, yin, yang or blood (xue). Risk factors for
hypertension are quite identical in these two medical sys-
tems and stress the observed strong association between
TOD with manifestations and Zangfu patterns.
Implications for proper antihypertensive agents selection
While current pharmacological treatment for hyperten-
sion is based on the level of SBP and DBP and the level
of total cardiovascular risk [29], however, Chinese medi-
cine diagnosis with disease subtyping may provide
insights into optimization of classes of antihypertensive
medications for TOD management. For instance,
research suggests that specific agents work better in
treating hypertension with particular patterns, eg cal-
cium channel blockers for phlegmatic damp excess pat-
tern and blood stasis; b-blockers for liver-yang rising;
angiotensin converting enzyme inhibitors for yin-defi-
ciency and yang-hyperactivity or combined liver-yin and
kidney-yin deficiency [22]. The therapeutic potential of
several antihypertensive agents (diuretics, angiotensin
converting enzyme inhibitors, angiotensin II receptor
antagonists, b-blockers, calcium channel blockers and
aldosterone antagonism) have been shown to also
improve hypertension-induced TOD [32]. However, the
efficacy of antihypertensive agents, acupuncture and
herbs as well as the effects of such interventions on
TOD is yet to be determined.
Conclusion
Zangfu patterns are associated with clinical manifesta-
tions of TOD. Manifestations associated patterns
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indicate morbid conditions to be secondary to hyperten-
sion rather than simple blood pressure.
Additional material
Additional file 1: Zangfu patterns hypertension dataset (ZFHD). This
table presents the complete description of manifestations regarding
Zangfu patterns and distributed among the Examination methods
Additional file 2: Representative cases for each Zangfu pattern in
hypertension. This table presents a representative case for each
diagnosis, including its manifestations and tongue pictures for illustration
of cases.
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